44.97
price down icon3.95%   -1.85
pre-market  시장 영업 전:  45.00   0.03   +0.07%
loading
전일 마감가:
$46.82
열려 있는:
$47
하루 거래량:
10,251
Relative Volume:
0.29
시가총액:
$275.00M
수익:
-
순이익/손실:
$-7.12M
주가수익비율:
-19.55
EPS:
-2.3
순현금흐름:
$-6.82M
1주 성능:
-3.25%
1개월 성능:
+40.88%
6개월 성능:
+8.47%
1년 성능:
+6,766%
1일 변동 폭
Value
$44.37
$47.00
1주일 범위
Value
$44.26
$48.35
52주 변동 폭
Value
$0.3438
$54.30

Monopar Therapeutics Inc Stock (MNPR) Company Profile

Name
명칭
Monopar Therapeutics Inc
Name
전화
(847) 388-0349
Name
주소
1000 SKOKIE BLVD SUITE 350, WILMETTE
Name
직원
16
Name
트위터
Name
다음 수익 날짜
2024-11-07
Name
최신 SEC 제출 서류
Name
MNPR's Discussions on Twitter

MNPR을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
MNPR
Monopar Therapeutics Inc
44.97 286.31M 0 -7.12M -6.82M -2.30
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Monopar Therapeutics Inc Stock (MNPR) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-07-07 개시 Cantor Fitzgerald Overweight
2025-06-23 개시 Chardan Capital Markets Buy
2025-03-19 재개 Piper Sandler Overweight
2025-01-10 개시 Piper Sandler Overweight
2024-10-11 개시 Rodman & Renshaw Buy
2021-01-28 개시 ROTH Capital Buy
모두보기

Monopar Therapeutics Inc 주식(MNPR)의 최신 뉴스

pulisher
06:14 AM

Monopar Therapeutics Inc. stock trend outlook and recovery path Free Growth Based Investment Plan Guidance - Newser

06:14 AM
pulisher
03:23 AM

How strong is Monopar Therapeutics Inc. company’s balance sheetSuperior returns - jammulinksnews.com

03:23 AM
pulisher
01:00 AM

What is the dividend policy of Monopar Therapeutics Inc. stockRetirement Planning Entry Points For Consistent Profits - jammulinksnews.com

01:00 AM
pulisher
12:49 PM

Does Monopar Therapeutics Inc. stock perform well during market downturnsAchieve superior capital gains with smart trades - jammulinksnews.com

12:49 PM
pulisher
12:12 PM

What are analysts’ price targets for Monopar Therapeutics Inc. in the next 12 monthsGet professional advice for market timing - jammulinksnews.com

12:12 PM
pulisher
Jul 27, 2025

How many analysts rate Monopar Therapeutics Inc. as a “Buy”Invest confidently with real-time data analysis - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What is the risk reward ratio of investing in Monopar Therapeutics Inc. stockMaster stock selection with insider knowledge - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

When is the best time to buy Monopar Therapeutics Inc. stockLow Risk Trade Timing Signals - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

What makes Monopar Therapeutics Inc. stock price move sharplyFree Stock Selection with 300% Return - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

Why Monopar Therapeutics Inc. stock attracts strong analyst attentionFree Predictions - metal.it

Jul 27, 2025
pulisher
Jul 25, 2025

What drives Monopar Therapeutics Inc. stock priceAccelerated capital growth - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Is Monopar Therapeutics Inc. a good long term investmentPhenomenal returns - Autocar Professional

Jul 25, 2025
pulisher
Jul 25, 2025

Does Monopar Therapeutics Inc. stock pay reliable dividendsConsistent double returns - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 24, 2025

What analysts say about Monopar Therapeutics Inc. stockFree Stock Index Interpretation - Autocar Professional

Jul 24, 2025
pulisher
Jul 22, 2025

Monopar Therapeutics Inc. Stock Analysis and ForecastFree Investment Community - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

Long Term Trading Analysis for (MNPR) - news.stocktradersdaily.com

Jul 21, 2025
pulisher
Jul 20, 2025

Is TBMCR a good long term investmentExplosive trading opportunities - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 19, 2025

Technical Analysis: Sreeleathers Limited (535601)Tremendous portfolio expansion - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 19, 2025

Is Siddhi Acquisition Corp. Debt Equity Composite Units a good long term investmentMarket-crushing profits - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 18, 2025

Las Vegas Sands Corp. Stock Analysis and ForecastMassive wealth growth - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 18, 2025

Best Stocks for Risk Averse Investors Market Trend Prediction ToolsFree Stock Chart Pattern Guide - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 18, 2025

Monopar Therapeutics Inc. (NASDAQ:MNPR) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World

Jul 18, 2025
pulisher
Jul 18, 2025

Institutional Investors Control 29% of Monopar Therapeutics Inc. (NASDAQ:MNPR) and Were Rewarded Last Week After Stock Increased 23% - 富途牛牛

Jul 18, 2025
pulisher
Jul 18, 2025

What analysts say about Monopar Therapeutics Inc. stock outlook5x Profit Potential - Newser

Jul 18, 2025
pulisher
Jul 16, 2025

Monopar therapeutics director Tsuchimoto sells $356k in stock By Investing.com - Investing.com Canada

Jul 16, 2025
pulisher
Jul 16, 2025

Monopar therapeutics director Starr sells $672k in stock By Investing.com - Investing.com Canada

Jul 16, 2025

Monopar Therapeutics Inc (MNPR) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Monopar Therapeutics Inc 주식 (MNPR) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
STARR CHRISTOPHER M
Director
Jul 14 '25
Sale
40.00
16,800
672,020
5,173
Robinson Chandler
Chief Executive Officer
Jul 14 '25
Sale
40.00
16,800
672,020
73,472
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
자본화:     |  볼륨(24시간):